These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks. Smith LM; Willmore E; Austin CA; Curtin NJ Clin Cancer Res; 2005 Dec; 11(23):8449-57. PubMed ID: 16322308 [TBL] [Abstract][Full Text] [Related]
3. [PARP inhibitors for cancer therapy]. Saito H; Miki Y Gan To Kagaku Ryoho; 2011 Jan; 38(1):12-8. PubMed ID: 21368455 [TBL] [Abstract][Full Text] [Related]
4. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1. Veuger SJ; Curtin NJ; Richardson CJ; Smith GC; Durkacz BW Cancer Res; 2003 Sep; 63(18):6008-15. PubMed ID: 14522929 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of poly(ADP-ribose) polymerase in cancer. Plummer ER Curr Opin Pharmacol; 2006 Aug; 6(4):364-8. PubMed ID: 16753340 [TBL] [Abstract][Full Text] [Related]
6. Clinical poly(ADP-ribose) polymerase inhibitors for the treatment of cancer. Lewis C; Low JA Curr Opin Investig Drugs; 2007 Dec; 8(12):1051-6. PubMed ID: 18058575 [TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer: an update. Horvath EM; Szabó C Drug News Perspect; 2007 Apr; 20(3):171-81. PubMed ID: 17520094 [TBL] [Abstract][Full Text] [Related]
8. Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity? Papeo G; Forte B; Orsini P; Perrera C; Posteri H; Scolaro A; Montagnoli A Expert Opin Ther Pat; 2009 Oct; 19(10):1377-400. PubMed ID: 19743897 [TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic. Yap TA; Sandhu SK; Carden CP; de Bono JS CA Cancer J Clin; 2011; 61(1):31-49. PubMed ID: 21205831 [TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Jagtap P; Szabó C Nat Rev Drug Discov; 2005 May; 4(5):421-40. PubMed ID: 15864271 [TBL] [Abstract][Full Text] [Related]
11. The potential of PARP inhibitors in genetic breast and ovarian cancers. Drew Y; Calvert H Ann N Y Acad Sci; 2008 Sep; 1138():136-45. PubMed ID: 18837894 [TBL] [Abstract][Full Text] [Related]
12. Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology. Ratnam K; Low JA Clin Cancer Res; 2007 Mar; 13(5):1383-8. PubMed ID: 17332279 [TBL] [Abstract][Full Text] [Related]
13. [Poly(ADP-ribose) polymerase-1 as a regulator of protein-nucleic acid interactions in the processes responding to genotoxic action]. Sukhanova MV; Lavrik OI; Khodyreva SN Mol Biol (Mosk); 2004; 38(5):834-47. PubMed ID: 15554186 [TBL] [Abstract][Full Text] [Related]
15. Radiosensitization of human and rodent cell lines by INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase. Brock WA; Milas L; Bergh S; Lo R; Szabó C; Mason KA Cancer Lett; 2004 Mar; 205(2):155-60. PubMed ID: 15036647 [TBL] [Abstract][Full Text] [Related]
16. PARP inhibitors in breast cancer. Telli ML; Ford JM Clin Adv Hematol Oncol; 2010 Sep; 8(9):629-35. PubMed ID: 21157412 [TBL] [Abstract][Full Text] [Related]
17. Poly(ADPR)polymerase inhibition and apoptosis induction in cDDP-treated human carcinoma cell lines. Gambi N; Tramontano F; Quesada P Biochem Pharmacol; 2008 Jun; 75(12):2356-63. PubMed ID: 18468580 [TBL] [Abstract][Full Text] [Related]
18. Putting poly (ADP-ribose) polymerase and other DNA repair inhibitors into clinical practice. Helleday T Curr Opin Oncol; 2013 Nov; 25(6):609-14. PubMed ID: 24097104 [TBL] [Abstract][Full Text] [Related]
19. Toward specific functions of poly(ADP-ribose) polymerase-2. Yélamos J; Schreiber V; Dantzer F Trends Mol Med; 2008 Apr; 14(4):169-78. PubMed ID: 18353725 [TBL] [Abstract][Full Text] [Related]
20. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Eltze T; Boer R; Wagner T; Weinbrenner S; McDonald MC; Thiemermann C; Bürkle A; Klein T Mol Pharmacol; 2008 Dec; 74(6):1587-98. PubMed ID: 18809672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]